Persistent epithelial defect following penetrating keratoplasty: An adverse effect of diclofenac eyedrops

J. Shimazaki, H. Saito, H. Y. Yang, I. Toda, H. Fujishima, Kazuo Tsubota

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Associations between the use of diclofenac sodium (DfNa) eyedrops and the development of a postkeratoplasty persistent epithelial defect (PED) of the cornea were studied. In 100 consecutive patients undergoing penetrating keratoplasty who had no limbal or conjunctival epithelial abnormalities, 12 (12.0%) developed PED (persistence of epithelial defect for >8 days after keratoplasty) postoperatively. The use of DfNa eyedrops correlated significantly with the development of PED (p = 0.0001, chi-square test). DfNa eyedrops were used in 19 eyes postoperatively, eight of which (42.1%) showed signs of PED. The type of preservation media, preservation time, indications for keratoplasty, or the surgical procedures performed did not correlate with the development of PED. These results indicate that DfNa eyedrops are toxic to the corneal epithelium postkeratoplasty. The eyedrops should be used with great care in patients with disorders of the corneal epithelium.

Original languageEnglish
Pages (from-to)623-627
Number of pages5
JournalCornea
Volume14
Issue number6
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Penetrating Keratoplasty
Ophthalmic Solutions
Diclofenac
Corneal Epithelium
Corneal Transplantation
Poisons
Chi-Square Distribution
Cornea
Patient Care

Keywords

  • Corneal epithelium
  • Corneal transplantation
  • Sodium Diclofenac

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Shimazaki, J., Saito, H., Yang, H. Y., Toda, I., Fujishima, H., & Tsubota, K. (1995). Persistent epithelial defect following penetrating keratoplasty: An adverse effect of diclofenac eyedrops. Cornea, 14(6), 623-627.

Persistent epithelial defect following penetrating keratoplasty : An adverse effect of diclofenac eyedrops. / Shimazaki, J.; Saito, H.; Yang, H. Y.; Toda, I.; Fujishima, H.; Tsubota, Kazuo.

In: Cornea, Vol. 14, No. 6, 1995, p. 623-627.

Research output: Contribution to journalArticle

Shimazaki, J, Saito, H, Yang, HY, Toda, I, Fujishima, H & Tsubota, K 1995, 'Persistent epithelial defect following penetrating keratoplasty: An adverse effect of diclofenac eyedrops', Cornea, vol. 14, no. 6, pp. 623-627.
Shimazaki, J. ; Saito, H. ; Yang, H. Y. ; Toda, I. ; Fujishima, H. ; Tsubota, Kazuo. / Persistent epithelial defect following penetrating keratoplasty : An adverse effect of diclofenac eyedrops. In: Cornea. 1995 ; Vol. 14, No. 6. pp. 623-627.
@article{c05ed40a797a4b6499546fa8a80b11fe,
title = "Persistent epithelial defect following penetrating keratoplasty: An adverse effect of diclofenac eyedrops",
abstract = "Associations between the use of diclofenac sodium (DfNa) eyedrops and the development of a postkeratoplasty persistent epithelial defect (PED) of the cornea were studied. In 100 consecutive patients undergoing penetrating keratoplasty who had no limbal or conjunctival epithelial abnormalities, 12 (12.0{\%}) developed PED (persistence of epithelial defect for >8 days after keratoplasty) postoperatively. The use of DfNa eyedrops correlated significantly with the development of PED (p = 0.0001, chi-square test). DfNa eyedrops were used in 19 eyes postoperatively, eight of which (42.1{\%}) showed signs of PED. The type of preservation media, preservation time, indications for keratoplasty, or the surgical procedures performed did not correlate with the development of PED. These results indicate that DfNa eyedrops are toxic to the corneal epithelium postkeratoplasty. The eyedrops should be used with great care in patients with disorders of the corneal epithelium.",
keywords = "Corneal epithelium, Corneal transplantation, Sodium Diclofenac",
author = "J. Shimazaki and H. Saito and Yang, {H. Y.} and I. Toda and H. Fujishima and Kazuo Tsubota",
year = "1995",
language = "English",
volume = "14",
pages = "623--627",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Persistent epithelial defect following penetrating keratoplasty

T2 - An adverse effect of diclofenac eyedrops

AU - Shimazaki, J.

AU - Saito, H.

AU - Yang, H. Y.

AU - Toda, I.

AU - Fujishima, H.

AU - Tsubota, Kazuo

PY - 1995

Y1 - 1995

N2 - Associations between the use of diclofenac sodium (DfNa) eyedrops and the development of a postkeratoplasty persistent epithelial defect (PED) of the cornea were studied. In 100 consecutive patients undergoing penetrating keratoplasty who had no limbal or conjunctival epithelial abnormalities, 12 (12.0%) developed PED (persistence of epithelial defect for >8 days after keratoplasty) postoperatively. The use of DfNa eyedrops correlated significantly with the development of PED (p = 0.0001, chi-square test). DfNa eyedrops were used in 19 eyes postoperatively, eight of which (42.1%) showed signs of PED. The type of preservation media, preservation time, indications for keratoplasty, or the surgical procedures performed did not correlate with the development of PED. These results indicate that DfNa eyedrops are toxic to the corneal epithelium postkeratoplasty. The eyedrops should be used with great care in patients with disorders of the corneal epithelium.

AB - Associations between the use of diclofenac sodium (DfNa) eyedrops and the development of a postkeratoplasty persistent epithelial defect (PED) of the cornea were studied. In 100 consecutive patients undergoing penetrating keratoplasty who had no limbal or conjunctival epithelial abnormalities, 12 (12.0%) developed PED (persistence of epithelial defect for >8 days after keratoplasty) postoperatively. The use of DfNa eyedrops correlated significantly with the development of PED (p = 0.0001, chi-square test). DfNa eyedrops were used in 19 eyes postoperatively, eight of which (42.1%) showed signs of PED. The type of preservation media, preservation time, indications for keratoplasty, or the surgical procedures performed did not correlate with the development of PED. These results indicate that DfNa eyedrops are toxic to the corneal epithelium postkeratoplasty. The eyedrops should be used with great care in patients with disorders of the corneal epithelium.

KW - Corneal epithelium

KW - Corneal transplantation

KW - Sodium Diclofenac

UR - http://www.scopus.com/inward/record.url?scp=0028862863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028862863&partnerID=8YFLogxK

M3 - Article

C2 - 8575187

AN - SCOPUS:0028862863

VL - 14

SP - 623

EP - 627

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 6

ER -